Topics

Latest "Behavioural Vestibular Diseases" News Stories

20:00 EST 28th February 2020 | BioPortfolio

Here are the most relevant search results for "Behavioural Vestibular Diseases" found in our extensive news archives from over 250 global news sources.

More Information about Behavioural Vestibular Diseases on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Behavioural Vestibular Diseases for you to read. Along with our medical data and news we also list Behavioural Vestibular Diseases Clinical Trials, which are updated daily. BioPortfolio also has a large database of Behavioural Vestibular Diseases Companies for you to search.

Showing "Behavioural Vestibular Diseases" News Articles 1–25 of 6,200+

Friday 28th February 2020

Don’t Be A Super Spreader - Advice In The Face Of A Global Pandemic

A Warning From First Aid Global That The Super Spreaders Are Among Us, All We Need Now Is A Virus LOS ANGELES (PRWEB) February 28, 2020 At the very heart of Korea's Coronavirus Outbreak is the Shincheonji religious group where being ill was no deterent to mandatory attendance in crowded conditions at the church in Daegu, South Korea. There, a parishioner easily spread it to the thousands who ...


Coronavirus IS a Pandemic — WHO, Declare It Now!

Since AIDS Healthcare Foundation (AHF) released a

Ping An Launches COVID-19 Smart Image-Reading System to Help Control the Epidemic

HONG KONG and SHANGHAI, Feb. 28, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 02318; SSE: 601318) announced that the Corona Virus Disease 2019 (COVID-19) smart image-reading system was launched on 19 February. It was developed by Ping An Smart Healthcare, the smart health care...


Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants

Aptorum Group Limited (NASDAQ:APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced the closing of a registered direct offering of 1,351,350 Class A ordinary shares at a per share offering price of $7.40. The investors also received accompanying warrants to purchase 1,351,350 of its Class A o...

Quantzig’s Analytics Experts Analyze How Predictive Analytics and Big Data Can Help Tackle a Pandemic Like Coronavirus

Get in touch for comprehensive solution insights Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent article that examines the role of predictive analytics in healthcare by listing out the top

LOTTE Vietnam Shopping Joint Stock Company donates medical masks for the Hospital for Tropical Diseases

HO CHI MINH CITY, Vietnam, Feb. 28, 2020 /PRNewswire/ -- LOTTE Vietnam Shopping Joint Stock Company donated 30,000 medical masks of Choice L brand to the Hospital for Tropical Diseases in Ho Chi Minh City to help reverse the Covid-19 epidemic. Given the complicated situation of Covid-19, the demand of medial masks has rapidly increased, leading to scarcity among hospitals and clinics. Furthermore...

Biogen and Sangamo Partner to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases

CAMBRIDGE, Mass. & BRISBANE, Calif.–(BUSINESS WIRE)–Biogen Inc. (Nasdaq: BIIB) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a global licensing collaboration agreement to develop and commercialize ST-501 for tauopathies including Alzheimer’s disease, ST-502 for synucleinopathies including Parkinson’s disease, ...

Horizon and Willis Tower Elevate the Need for Rare Disease Innovation on Rare Disease Day

Horizon Therapeutics (Nasdaq: HZNP) and Willis Towers Watson (Nasdaq: WLTW) are partnering with Willis Tower to light the antennas of the Willis Tower on Feb. 29 in recognition of Rare Disease Day and to raise awareness of the crucial need to identify new medicines for the 30 million people living with rare diseases in the United States. The antennas will be illuminated in the colors of the risin...

JLK Inspection has announced signing of a partnership with the National TB Center (NTC) and the Clinton Health Access Initiatives (CHAI) in Lao PDR to conduct a tuberculosis screening project

- Accelerating overseas expansion of AI-based lung diseases analysis solution, 'JLD-02K'. SEOUL, South Korea, Feb. 28, 2020 /PRNewswire/ -- JLK Inspection Inc., a Korean company specializing in Artificial Intelligence based medical analysis solutions, has announced a recent signing of an agreement with the Clinton Health Access Initiative (CHAI) in Lao PDR, a...

COVID-19 a reminder of the challenge of emerging infectious diseases

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write scientists.

Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology

SUNNYVALE, Calif., and CAMBRIDGE, Mass., Feb. 28, 2020 /PRNewswire/ — Cepheid and Sherlock Biosciences today announced a research collaboration between the two companies to explore the development of new cutting-edge molecular diagnostic tests. Leveraging Sherlock Biosciences’ engineering biology platform, SHERLOCK™, a CRISPR-based technology that can identify virtually any g...

Horizon Therapeutics plc Partners with EveryLife Foundation to Establish $1 Million RAREis Scholarship for Adults with Rare Diseases

Horizon Therapeutics plc (Nasdaq: HZNP) today announced a $1 million commitment over five years to establish the RAREis scholarship, a program that will be made available by the EveryLife Foundati...

Hybrid T Cells May Open Door to Novel Vaccines and Autoimmune Disease Therapies

Researchers at Trinity College Dublin have identified a rare, new 'Jekyll and Hyde' immune cell. The findings should help scientists design more effective vaccines to prevent infections, and may help develop new therapies for autoimmune diseases. The post Hybrid T Cells May Open Door to Novel Vaccines and Autoimmune Disease Therapies appeared first on GEN - Genetic Engineering and Biotechnology Ne...

Respivant Sciences Supports International Rare Disease Day Through Awareness Activities

Respivant also announces 50% enrollment milestone achieved in SCENIC, a Phase 2b Trial of RVT-1601 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Respivant Sciences, a clinical-stage biopharmaceutical company dedicated to developing new therapies for patients with rare respiratory diseases, today announced its support of Rare

Horizon Therapeutics plc Partners with EveryLife Foundation to Establish $1 Million #RAREis Scholarship for Adults with Rare Diseases

Horizon Therapeutics plc (Nasdaq: HZNP) today announced a $1 million commitment over five years to establish the #RAREis scholarship, a program that will be made available by the EveryLife Foundation for Rare Diseases. The #RAREis scholarship will support the pursuit of life enrichment activities for adults living with rare diseases for a variety of educational pursuits, including educational cou...

New medicines against severe inflammatory diseases

The Lead Discovery Center GmbH (LDC), the Max Planck Society (MPG) and Max Planck Innovation (MI) announce that their associated company Quench Bio Inc., Cambridge, USA has raised USD 50 million in a Series A financing round. The financing was led by RA Capital Management (RA Capital) and included A...

A study in Nature shows important differences between the male and female immune system, which may explain why men are more susceptible to obesity and metabolism-related associated diseases, such as heart disease, stroke and diabetes. https://go.nature.c

A study in Nature shows important differences between the male and female immune system, which may explain why men are more susceptible to obesity and metabolism-related associated diseases, such as heart disease, stroke and diabetes. https://go.nature.com/3cfqpEs  pic.twitter.com/9XAfcz3xaQ

Aorta and Peripheral Circulation: The Year in Cardiology 2019

Review the groundbreaking science published in 2019 in the area of aortic and peripheral arterial diseases as well as venous thromboembolic disease. European Heart Journal

 Coronavirus Business Travel Guidelines…Don’t Travel

Search Firm Jeff Christian Partners Tells Clients and Candidates Not To Travel Jeff Christian Partners a leading search firm has advised their CEO, C-Suite clients and candidates to cancel all business travel and conduct interviews by video. Jeff Christian explains, “ search firms encourage a strong percentage of business travel and we should not put anyone at risk. As a result we are advisi...

Ra Pharmaceuticals Supports 13th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) is joining forces with 30 million healthcare advocates around the world for the 13th Annual Rare Disease Day®, an awareness day dedicated to elevating public understanding of rare diseases and calling attention to the special challenges people living with rare diseases face. “At Ra Pharma, our primary focus is the patients and communities we serve. Thes...

Biogen, Sangamo team up on neurological diseases

The companies have detailed plans to leverage Sangamo’s proprietary zinc finger protein (ZFP) technology.

Biogen and Sangamo to develop neurological disease drugs

Biogen and Sangamo Therapeutics have signed a global licensing agreement for the development of drugs to treat neurological diseases, including...Read More... The post Biogen and Sangamo to develop neurological disease drugs appeared first on Pharmaceutical Technology.

Harbour BioMed Announces U.S. FDA Approval of IND for Its Next Generation anti-CTLA-4 Antibody, HBM4003, to Treat Cancer

First fully human, heavy chain only antibody in human trials has shown potent activity in preclinical studies through differentiated mechanism of action Harbour BioMed (HBM) today announced U.S. Food and Drug Administration (FDA) approval of its Investigational New Drug (IND) application to begin clinical studies with HBM4003, its next generation anti-CTLA-4 antibody for the treatment of cancer....

The Challenges Of Combating Rare Diseases - And Five Innovations Making A Real Difference

With February 29th 2020 being Rare Disease Day, I want to examine why rare diseases are still overlooked, and look at the innovations that are helping to bridge the gap.

Mayo Clinic's Web Site Contains a "Find Diseases and Conditions" Feature

Searching for reliable web sites that discuss the diagnosis of diseases can be a hit-or-miss proposition. The process is sometimes jokingly referred to as "consulting Dr. Google" (see: The precautions you should take before consulting ‘Dr. Google’). Regarding the use of lab tests for diagnosis, one of the best resources...


Quick Search

News Quicklinks